OBJECTIVE:To understand the gap between and common regularity of China and USA in development of drug retail chain management METHODS:The sales volume,number of drugstore and the average sales volume of a drugstore of Chinese and American drug retail chain enterprises were collected and analysed These enterprises occupied the front 50 places in sales volume RESULTS & CONCLUSION:There exists a wide gap between Chinese and American drug retail chain enterprises,however,Chinese enterprises can improve the market competition ability and gradually reduce the distinction between China and America in management through scientific expanding strategy

OBJECTIVE:To discuss the method of selecting the site of drugstore for pharmaceutical reail chain enterpris?es.METHODS:To introduce the theory of selecting the site of retail chain store in other business.RESULTS&CONCLU?SION:Pharmaceutical retail chain enterprises should select the site of drugstore by four steps:judging feasibility of opening a drugstore in a region,analyzing the site and area of the drugstore,forecasting the sales volumn and profit of the adding drug?store,starting the business and carrying out periodical estimation.

OBJECTIVE:To provide reference information for promoting human resource management of pharmaceutical retail chain enterprises in China METHODS:Analyzing the human resource characteristics and existing problems in Chinese pharmaceutical retail chain enterprises RESULTS & CONCLUSION:Chinese pharmaceutical retail chain enterprises should carry out human resource management in four aspects:making human resource program,choosing the personnel,training the personnel and assessing the personnel

OBJECTIVE:To discuss the developmental environments suitable for Chinese biopharmacy.METHODS:The developmental environments of Chinese pharmacy on policy,law,finance and information were analyzed in view of the char?acteristics of Chinese pharmacy.RESULTS&CONCLUSION:In order to push forward the developmental proceedings of Chinese biopharmacy,policies like Research&Development,products transfer,patent application and registration approval,industrialization,human resources management,marketing,international cooperation etc.of Chinese biopharmacy should be kept improving,and the environments on law,finance and information of biopharmacy should also be optimized.

OBJECTIVE:To provide references for the supervisors of licensed pharmacists and other correlative personnel in mainland of China.METHODS:The related information on the licensed pharmacists in Hong Kong,Macao,Taiwan and mainland of China were compared and analyzed.RESULTS&CONCLUSION:The licensed pharmacists in Hong Kong,Macao,Taiwan are different from those in the mainland of China in terms of the legal bases for management,the control agency,classification and numbers,distribution,qualifications for access,education and continuing education etc.The mainland of China can draw merits from Hong Kong,Macao and Taiwan to further perfect its management on the licensed pharmacists.

OBJECTIVE: To explore the developmental modes of Chinese biopharmaceutics for the references of institutions of higher learning, scientific research institutions, enterprises and governmental branches.METHODS: Problems in Chinese biopharmaceutical research & development and its industrialization were analyzed and modes suitable for Chinese biopharmaceutical development were put forward.RESULTS & CONCLUSION: In order to promote the development of biopharmaceutics effectively, biopharmaceutical talents reserve mode, industry - university - laboratory cooperation mode, research & development mode, step-by-step exploitation mode, marketing mode, modern corporation operation mode, industry assembly mode, international cooperative mode, etc.can be applied in China.

Innate immunity plays an important role in inflammatory injury after cerebral ischemia,and inflammasome is considered to be a key factor.Inflammasome is a macromolecular protein complex,can recognize pathogen-associated molecular patterns and damage-associated molecular patterns,and mediate immune inflammatory responses.Studies have shown that cerebral ischemia can induce the acute activation of the NLRP1 and NLRP3 inflammasomes.This article reviews the structure,activation and regulation of inflammasome,and the roles of inflammasome in cerebral ischemia.

OBJECTIVE:To provide information for diversified operation of Chinese pharmaceutical retail chain enterprises.METHODS:By means of introducing the concept of commodity management,its effective application in Chinese pharmaceutical retail chain enterprises was analysed.RESULTS&CONCLUSION:Chinese pharmaceutical retail chain enterprises should apply commodity management theory to searching the mode of diversified operation,for improving net sales and market competition ability.

The experiences and characteristics of professor ZHANG Yu-lian in regulating marrow sea acupuncture for treatment of post-stroke ataxia is introduced. Professor ZHANG established regulating marrow sea acupuncture based on the fundamentals of traditional Chinese medicine combined with brain functional region projection and cerebrovascular distribution of modern medicine. "Three acupoints regulating balance" "3 acupoints regulating transportation" "3 acupoints regulating tremor" and Fengchi (GB 20), Fengfu (GB 16), Wangu (GB 12), Tianzhu (BL 10) and C3-C6 Jiaji (Ex-B2) acupoints were applied in this kind of manipulation. We combined holding spirits of doctor and patient together, and controlled the sensation transduction with different manipulations to reach the foci, which emphasis on the doctor-patient cooperation and body-mind co-regulation, finally promote patients' comprehensive rehabilitation.
Acupuncture Points ; Acupuncture Therapy ; history ; methods ; Ataxia ; etiology ; history ; therapy ; China ; History, 20th Century ; History, 21st Century ; Humans ; Stroke ; complications

The past decade has witnessed the remarkable progress on nanotechnology and nanoherb. With the globally rapid development of nanotechnology, we are considering to construct new nanoformula systems of traditional Chinese medicine (TCM) by using porous materials, multilayered core-shell particles or nanoparticles containing various multifunctional parts. With the compatibility of sovereign, minister, assistant and courier in a formula, new nanoformula systems of TCM will have various advantages, such as containing multiple active species, controlled release, targeting function, and labeling and tracing capabilities. Using the latest breakthroughs of nanotechnology for the modern research of TCM will greatly help enhance the ability to investigate the principles of TCM, and to design, screen and utilize new nanoformula systems of TCM.